Nipro Corporation operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nipro with three other
medical equipment manufacturers in Asia:
sales of 525.03 billion Japanese Yen [US$4.66 billion]
of which 49%
was Cardiovascular area business),
Shandong Weigao Group Medical Polymer Company Ltd
(6.73 billion Chinese Renmimbi [US$974.15 million]
JMS Co Ltd
(57.64 billion Japanese Yen [US$511.81 million]
of which 65%
was Operating Segment-Japan).
During the year ended March of 2016, sales at
Nipro were ¥366.65 billion (US$3.26 billion).
increase of 12.8%
versus 2015, when the company's sales were ¥325.08 billion.
This was the fifth consecutive year of sales increases at Nipro
(and since 2011, sales have increased a total of 87%).
Sales of Medical Care saw an increase
14.5% in 2016, from
¥237.78 billion to ¥272.17 billion.
Not all segments of Nipro experienced an increase in sales in 2016:
sales of Other fell 69.2% to ¥32.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).